A Minimal beta-Lactone Fragment for Selective beta 5c or beta 5i Proteasome Inhibitors.
Groll, M., Korotkov, V.S., Huber, E.M., de Meijere, A., Ludwig, A.(2015) Angew.Chem.Int.Ed.Engl. 54: 7810-7814
- PubMed: 25973989 
- DOI: 10.1002/anie.201502931
- PubMed Abstract: 
Broad-spectrum proteasome inhibitors are applied as anticancer drugs, whereas selective blockage of the immunoproteasome represents a promising therapeutic rationale for autoimmune diseases. We here aimed at identifying minimal structural elements th ...